Cardiovascular Medicine IN THE DEPARTMENT OF MEDICINE

Emil deGoma, MD

Clinical Fellow in Cardiovascular Medicine


Address

Emil deGoma, MD

Specialties:

  • Cardiology

Undergraduate School:

  • Harvard University
    BA, 1993-1997
    Cambridge, MA

Medical School:

  • Harvard Medical School
    MD, 1997-2003
    Boston, MA

Residency:

  • Internal Medicine
    Stanford University Medical Center
    Stanford, CA, 2003-2006
  • Internal Medicine Chief Residency
    Stanford University Medical Center
    Stanford, CA, 2006-2007

Fellowship:

  • Stanford University Medical Center
    Stanford, CA, 2007-present

Board Certification:

  • Internal Medicine 2006

Clinical/Research Interests:

  • Preventive cardiology
  • High-density lipoprotein
    and reverse cholesterol transport
  • Decompensated heart failure

Selected Publications:

  • deGoma EM, deGoma RL, Rader DJ. Beyond HDL-cholesterol levels:
    Evaluating HDL function as influenced by pharmacotherapy. J Am Coll
    Cardiol 2008 (in press).
  • deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of
    HDL-cholesterol among patients with low LDL-cholesterol. J Am Coll
    Cardiol 2008; 51: 49-55.
  • Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA. Statin use in
    patients with extremely low LDL-cholesterol levels is associated with
    improved survival. Circulation 2007;116:613-8.
  • Rockson SG, deGoma EM, Fonarow GC. Reinforcing a continuum of care:
    In-hospital initiation of long-term secondary prevention following
    acute coronary syndromes. Cardiovasc Drugs Ther 2007;21:375-88.
  • Rockson SG, deGoma EM. Chapter 17: Peripheral arterial disease. In:
    Toth PP, Gotto AM, Jr., editors. Comprehensive Management of High Risk
    Cardiovascular Patients. Informa Healthcare, New York 2006.
  • deGoma EM, Vagelos RH, Fowler MB, Ashley EA. Emerging therapies for
    the management of decompensated heart failure: From bench to bedside.
    J Am Coll Cardiol 2006;48:2397-409.
  • deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of HDL-C
    levels among patients with LDL-C less than 60 mg/dl. AHA Scientific
    Sessions. Chicago, IL. November 15, 2006. Population Science Poster
    Competition Winner.

Stanford Medicine Resources:

Footer Links: